“…RNA contains complex and sophisticated higher order structures that are essential for recognition by other macromolecules and/or required for catalytic processes+ As such, it offers an interesting target for small molecule ligands and, indeed, the ability of RNA to interact with small molecules has long been recognized+ Antibiotics are a chemically and structurally diverse collection of molecules, with some classes capable of interacting with rRNA to exert profound effects on the translation process+ Functional insights from structural studies of compounds bound to ribosomal subunits have revealed that rRNA/small molecule ligand recognition is based on a combination of shape recognition, electrostatic, and hydrogen-bonding interactions Pioletti et al+, 2001;Schlunzen et al+, 2001)+ Additionally, RNA SELEX (Systematic Evolution of Ligands by Exponential Enrichment) has enabled the identification of minimal nucleic acid recognition motifs for ligand binding, demonstrating that RNA three-dimensional structures can form a large number of highly specific ligand-binding sites (Gold et al+, 1995)+ The ribosome is the target for many important antibacterial agents; these compounds interfere with essential steps of protein synthesis (Pestka, 1977;Gale et al+, 1981;Noller, 1991)+ Among these, 2-deoxystreptamine aminoglycosides (small polycationic compounds possessing linked ring systems consisting of aminosugars and an aminocyclitol) cause codon misreading by interfering with the decoding process + These compounds have found clinical use as antibacterial agents due to their ability to specifically bind bacterial ribosomes (Gale et al+, 1981) and are thought to exert their effects by increasing the error rate of the ribosome + Eukary-otic cytoplasmic ribosomes are relatively insensitive to 2-deoxystreptamine aminoglycosides (Kurtz, 1974;Palmer & Wilhelm, 1978;Wilhelm et al+, 1978aWilhelm et al+, , 1978b, and it has been suggested that the sensitivity of a ribosomal system to antibiotics is determined by the sequence of its rRNA (Sor & Fukuhara, 1984;Beckers et al+, 1995)+ Indeed, the nephrotoxicity and ototoxicity associated with use of aminoglycosides in the clinical setting may be linked to the susceptibility of mitochondrial ribosomes to these compounds (Bottger et al+, 2001)+ Aminoglycosides are also capable of binding to and affecting the activity of a large number of other RNAs, including the HIV TAR element (Mei et al+, 1997), HIV Rev-responsive element (Zapp et al+, 1993), hammerhead ribozymes (Stage et al+, 1995;Jenne et al+, 2001), hairpin ribozymes (Earnshaw & Gait, 1998), ribonuclease P RNA …”